Tractography Guided Subcallosal Cingulate Deep Brain Stimulation for Treatment Resistant Depression
NCT: NCT03952962 · RECRUITING
Brief Summary
Treatment resistant depression remains a major problem for individuals and society. Surgical procedures may provide relief for some of these patients. The most frequently considered surgical approach is deep brain stimulation (DBS) of a part of the brain called the subcallosal cingulate region. However, the effectiveness and safety is not well established. The investigators will use a novel approach using advanced imaging technique (magnetic resonance tractography) to evaluate the feasibility and safety of this surgical approach. An innovative method for the definition of DBS target will be applied that redefines the concept of targeting as one of targeting a symptomatic network rather than a structural brain region using subject-based brain anatomy to define the target location. The correlation between imaging findings at baseline with the mood score changes at different time points of the study will be investigated.
Frequently Asked Questions
What is Tractography Guided Subcallosal Cingulate Deep Brain Stimulation for Treatment Resistant Depression?
Tractography Guided Subcallosal Cingulate Deep Brain Stimulation for Treatment Resistant Depression is a clinical trial registered under NCT03952962. Current status: RECRUITING.
What is the status of NCT03952962?
The current status of NCT03952962 (Tractography Guided Subcallosal Cingulate Deep Brain Stimulation for Treatment Resistant Depression) is: RECRUITING.
When did Tractography Guided Subcallosal Cingulate Deep Brain Stimulation for Treatment Resistant Depression start?
Tractography Guided Subcallosal Cingulate Deep Brain Stimulation for Treatment Resistant Depression started on 2022-10-28.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.